Edwards Lifesciences (EW)
(Delayed Data from NYSE)
$66.83 USD
-0.43 (-0.64%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $66.84 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 10/23/24 |
---|---|
Current Quarter | 0.68 |
EPS Last Quarter | 0.70 |
Last EPS Surprise | 0.00% |
ABR | 2.35 |
Earnings ESP
|
-5.97% |
---|---|
Current Year | 2.71 |
Next Year | 2.83 |
EPS (TTM) | 2.59 |
P/E (F1) | 24.80 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.58B | 1.65B | 6.47B | 6.84B |
# of Estimates | 12 | 6 | 6 | 6 |
High Estimate | 1.61B | 1.66B | 6.48B | 7.07B |
Low Estimate | 1.52B | 1.64B | 6.46B | 5.95B |
Year ago Sales | 1.48B | 1.53B | 6.00B | 6.47B |
Year over Year Growth Est. | 6.98% | 7.47% | 7.81% | 5.66% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.68 | 0.70 | 2.71 | 2.83 |
# of Estimates | 13 | 6 | 8 | 8 |
Most Recent Consensus | 0.67 | 0.65 | 2.68 | 2.78 |
High Estimate | 0.70 | 0.72 | 2.77 | 3.01 |
Low Estimate | 0.63 | 0.69 | 2.56 | 2.60 |
Year ago EPS | 0.59 | 0.64 | 2.51 | 2.71 |
Year over Year Growth Est. | 15.25% | 9.38% | 7.97% | 4.25% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 3 | 0 | 1 | 0 |
Down Last 7 Days | 1 | 0 | 0 | 0 |
Down Last 30 Days | 2 | 0 | 0 | 0 |
Down Last 60 Days | 6 | 5 | 7 | 8 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.68 | 0.70 | 2.71 | 2.83 |
7 Days Ago | 0.68 | 0.70 | 2.71 | 2.83 |
30 Days Ago | 0.68 | 0.70 | 2.71 | 2.83 |
60 Days Ago | 0.69 | 0.73 | 2.77 | 3.11 |
90 Days Ago | 0.69 | 0.73 | 2.77 | 3.11 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.64 | 0.70 | 2.71 | 2.83 |
Zacks Consensus Estimate | 0.68 | 0.70 | 2.71 | 2.83 |
Earnings ESP | -5.97% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.70 | 0.66 | 0.64 | 0.59 | NA |
Estimate | 0.70 | 0.64 | 0.64 | 0.59 | NA |
Difference | 0.00 | 0.02 | 0.00 | 0.00 | 0.01 |
Surprise | 0.00% | 3.13% | 0.00% | 0.00% | 0.78% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more